NCT05843253
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05843253 |
| Title | Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Nationwide Children's Hospital |
| Indications | |
| Therapies | |
| Age Groups: | adult | child |
| Covered Countries | USA | NLD | GBR | DEU | CAN | AUS |
CKB BOOST